The Leadership Development Group is guided by an advisory board comprised of leaders across the health ecosystem and nationally recognized executives from various business disciplines including mergers and acquisitions, industrial and organizational psychology, general management, human resources, organizational development, and leadership development.
The advisors who comprise our board bring perspectives from different geographic areas and from all sectors – public, not-for-profit, and private. Due to their reputations, research, and demonstrated expertise, these board members are well-positioned to advise TLD Group on trends and current issues facing our clients which guide our strategic priorities.
Robert Sachs, PhD
Chair of the Advisory Board
Bob Sachs works with organizations to enhance and integrate critical leadership talent strategies and systems, on learning strategy and governance and he provides coaching to executives. He was Vice President of National Learning and Development at Kaiser Permanente until December 2015. His responsibilities at KP included succession management, leadership development and supporting the overall learning agenda of the organization. At Kaiser Permanente (KP) Bob designed and consulted with executives on executive development, leadership development, high potential identification and development and he developed and supported the succession management processes for the organization. He also led the team that provided learning services, including the enterprise learning management system, and designed learning solutions for KP’s enterprise National Functions. Prior to joining Kaiser, Dr. Sachs was Vice President and Managing Director of the Hay Group. Over his 16 years with Hay, his consulting focused on helping organizations enhance organizational performance through the design and implementation of systems and processes to ensure they have the right people, performing the right work motivated to produce superior results.
Poonam Alaigh, M.D.
Poonam Alaigh has been successful in both the public and private sectors of healthcare. Prior to joining Remedy Partners, Poonam was the Acting Under Secretary for Health at the Department of Veterans Affairs where she directed a healthcare system with an annual budget of approximately $61 billion, overseeing the delivery of care to more than 9 million enrolled veterans. Poonam was the Commissioner of the Department of Health and Senior Services of New Jersey, where she oversaw the department that was responsible for the healthcare policy, public health, senior care and quality of all the healthcare institutions in the state. She also served as the co-founder of one of the largest ACOs in the country, the Atlantic Accountable Care Organization, and CEO and President of Alaigh Care Associates, LLC, a national healthcare consulting company. She has held executive leadership positions at Horizon Blue Cross Blue Shield of New Jersey and GlaxoSmithKline. Poonan is a board certified internist with a specialty in vascular diseases having received her MD and her Masters in Health Care Policy and Management at the State University of New York at Stony Brook, NY. She is a certified Black Belt in Six Sigma business management strategy. She is a recognized national healthcare leader and has authored a number of articles and publications.
David Carmouche, M.D.
David Carmouche is a recognized visionary leader in the arenas of healthcare delivery, population health, and payer systems with a keen focus on both patient care and outcome metrics. David has demonstrated talent for strategic partnerships with C-suite leaders and Boards. David has demonstrated success in achieving operational results through cross-functional teams in complex environments and as a trusted leader of diverse groups with competing business interests through collaborative initiatives. Dr. Carmouche serves as Senior Vice-President and President of Ochsner Health Network. In that role, he is responsible for executive oversight and management for the rapidly growing, statewide network. Dr. Carmouche is also the Executive Director of Ochsner Accountable Care Network, a regional accountable care organization (ACO), comprised of an extensive network of providers, hospitals and health centers coordinating the healthcare of approximately 35,000 of Louisiana’s Medicare fee-for-service beneficiaries. Dr. Carmouche joined Ochsner with 19 years of progressive healthcare leadership experience in medicine and operations. Prior to joining Ochsner in August 2015, he served as the Executive Vice- President of External Operations and Chief Medical Officer at Blue Cross Blue Shield of Louisiana in Baton Rouge where he designed and deployed a physician-friendly, comprehensive primary care population health program and several commercial ACO contracts.
Glenn Frommer, MBA, CPA
Glenn Frommer is a business leader who has consistently transformed complex businesses to deliver increased enterprise value throughout a broad functional and international career in diverse specialty, industrial-products markets. Glenn is skilled in leading teams to improve margins and cash flow by focusing on accretive and complementary M&A, a strong drive for results, value selling, structured product innovation, and business restructuring. As the CEO & President of Mauser Group’s North American business and a Management Board member for Mauser Global, Glenn is responsible to grow enterprise value through acquisitions, margin improvement programs, operational excellence, and effective cash management. Glenn spent his career in the US and Europe with several large multi-national companies including Unilever, ICI, Celanese, and Ernst & Young, where he applied a combination of his technology background and financial experience in business management and financial leadership roles. He has spent his career focused on strategy and leadership development as the core elements of leading market-driven and technology-based businesses.
Ira Klein, MD, MBA, FACP
Ira Klein is the Senior Director of Health Care Quality Strategy in the Strategic Customer Group of Janssen Pharmaceuticals. As a 15-year health care industry veteran, his role is to advance Janssen’s ability to deliver industry-leading value-based solutions to the marketplace through engaging with and supporting providers in their efforts to improve quality reporting and performance. This will be grounded in Triple Aim solutions to Janssen’s advanced customers, and facilitated by a personal record of having worked on a variety of national quality and policy committees in D.C., and with many medical specialty societies and patient advocacy groups. Previously, Ira was employed by Aetna, where he held a variety of roles during his near 10 year tenure. Most recently, he was National Medical Director for Clinical Thought Leadership in the Office of the Chief Medical Officer, building value-based programs in oncology. He led quality and policy interactions with individual providers, vendors, ACO’s, pharmaceutical companies and other health systems, developing nationwide programs. In addition to oncology, he worked across multiple therapeutic areas including endocrinology and immunology. As Chief of Staff to the CMO at Aetna, he led policy and economic evaluation of the oncology medical cost category, which led to the establishment of the Oncology Solutions Group at Aetna, focusing on developing value-based programs.
Lorie K. Shoemaker, DHA, RN, MSN, DHA, NEA-BC
Lorie Shoemaker joined CHI St. Luke’s Health as the Senior Vice President and Chief Nursing Officer for the Texas Division in September, 2015. Dr. Shoemaker’s responsibilities include oversight for the quality of nursing care and nursing practice across the acute and post-acute care continuum. Prior to joining CHI St. Luke’s Health, Dr. Shoemaker served in a variety of leadership roles over a 29 year career at Palomar Health in San Diego, California, including the System Chief Nurse Executive from 2004 -2014. In this role, Dr. Shoemaker provided oversight for nursing care across the system that included three acute care hospitals, two skilled nursing facilities, as well as ambulatory and home health agencies. Under Dr. Shoemaker’s leadership, the entire health system received Magnet® recognition in 2009, making Palomar Health the first public health system in California to achieve this honor. Most recently, Dr. Shoemaker served as the President of Palomar Medical Center, the new, state-of-the art facility that she helped design and operationalize in 2012.
Russell Showers, MBA
Russ Showers is an experienced healthcare human resources leader known for his ability to collaborate with others, bring innovative strategies to the organizations he serves, and elevate performance and drive organizational transformation. He is a trusted coach and advisor to executive leadership. Currently, Russ serves as CHRO for Tower Health and is responsible for all facets of human resources operations, total rewards, talent acquisition, leadership development, talent management, organization change, performance management, and labor & employee relations for more than 11,000 team members. Tower Health is a regional integrated healthcare provider/payer system that offers healthcare and wellness services to a population of 2.5 million people in their six hospitals and other entities. Prior to joining Tower’s flagship hospital Reading Health in 2013, Russ served as VPHR for Valley Health System where he was responsible for strategic and operational leadership of all areas of human resources and organization development. Russ has also held HR leadership roles with the Children’s Hospital of Philadelphia and Geisinger Health System.
Ruth Wageman, Ph.D.
Ruth Wageman is one of the foremost scholars and practitioners studying and working with leadership teams. Understanding the conditions that influence superb team performance has been the core of Ruth’s research, teaching and consulting for the last thirty years. Ruth’s work places particular emphasis on modern challenges to organizations and society. She studies and develops the capacities that are needed to solve complex problems and to lead systems change. She builds collaborative leadership capacity within and across organizations, especially with multi-stakeholder leadership groups working to transform regional health. Ruth has been a professor at Columbia, Dartmouth, and Harvard, where she has led many original research programs about the design and leadership of teams. Based on her scholarly work, Ruth designed the Team Diagnostic Survey with Richard Hackman and Erin Lehman, a powerful, well-validated assessment that characterizes team effectiveness and how well the Six Conditions that drive effectiveness are established for that team; she leads accreditation workshops and supervises coaches in the use of the instrument in their practice.